Clustering data with hclust algorithm for A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UHPLC-QTOF MS analysis (Study ST000089)

UHPLC-QTOFMS positive ion mode (Analysis AN000141)
MetaboliteStructureF1F2F3F4F5F6F7
SM (d42:1)ME6569660.030.020.010.01NA3.323.15
PC (34:3)ME6568500.130.140.040.04NA2.522.70
SM (d41:1)ME6569650.140.120.040.04NA2.782.66
PC (38:3)ME656866NANA0.030.030.032.652.86
PC (18:1/16:0)ME656835NANA0.010.010.002.832.94
SM (d18:1/16:1)ME6569570.040.040.020.02NA2.992.89
NiacinamideME6568310.100.09NANANA1.712.67
PC (38:6) BME6568730.050.06NANANA1.542.93
PC (33:0)ME6568440.040.04NANANA2.362.27
PC (34:0)ME6568470.040.04NANANA2.322.30
1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholineME6567870.030.03NANANA2.352.30
plasmenyl-PE (34:1)ME6569280.030.03NANANA2.342.31
SM (34:1)ME6569430.010.01NANANA2.372.34
PC (33:1)ME6568450.020.02NANANA2.322.36
SM (34:0)ME6569420.020.02NANANA2.332.34
PC (35:2)ME6568530.040.04NANANA2.282.33
SM (d40:2) AME6569640.070.07NANANA2.252.29
PC (38:6) AME6568720.020.03NANANA2.322.18
PE (38:4)ME6569200.020.02NANANA2.402.13
PC (30:1)ME6568380.030.03NANANA2.512.18
PC (31:0)ME6568390.020.02NANANA2.532.18
PC (38:2)ME6568650.010.01NANANA2.462.26
PC (32:1)ME6568410.020.02NANANA2.412.28
PC (30:0)ME6568370.030.03NANANA2.442.23
PC (32:3)ME6568430.030.04NANANA2.442.21
PC (32:2)ME6568420.030.04NANANA2.402.25
SM (d18:2/23:0)ME6569600.030.03NANANA2.422.24
PC (38:5) AME6568700.040.04NANANA2.122.47
PC (35:1)ME6568520.040.04NANANA2.182.42
PC (38:4) BME6568690.040.05NANANA2.182.40
SM (d18:1/14:0)ME6569550.050.04NANANA2.212.21
plasmenyl-PE (36:1)ME6569300.090.10NANANA2.182.28
PC (33:2)ME6568460.100.11NANANA2.142.28
SM (d38:1)ME6569620.110.11NANANA2.152.27
PC (35:3)ME6568540.110.13NANANA1.942.41
plasmenyl-PC (34:2)ME6569270.150.18NANANA1.872.37
PC (40:5) AME656877NANA0.100.090.092.122.03
PS (36:2)ME6569390.070.09NANANA1.972.18
SM (33:1)ME6569410.050.06NANANA2.042.02
LPC (16:0)ME656821NANA0.100.12NA1.911.72
Ceramide (d40:1)ME6568010.470.53NANANA1.531.82
DG (38:4)ME6568130.420.49NANANA1.501.95
1-Stearoyl-2-oleoyl-sn-glycero-3-phosphoethanolamineME6567890.320.39NANANA1.871.89
Ceramide (d42:1)ME6568020.240.28NANANA1.992.03
PC (36:3) AME6568570.200.230.030.040.012.514.77
PC (34:2)ME6568490.460.560.060.070.012.973.93
PC (36:2)ME6568560.110.130.020.020.014.054.12
SM (d18:1/16:0)ME6569560.060.060.010.010.014.204.14
SM (d16:1/20:0)ME6569520.070.080.020.020.013.373.63
N-Tetracosenoyl-4-sphingenyl-1-O-phosphorylcholineME6568330.020.030.010.010.013.703.83
PC (16:0/16:0)ME6568340.040.050.010.010.003.683.64
SM (d40:1)ME6569630.100.100.020.020.013.583.55
PC (36:4)ME6568580.060.070.030.040.033.284.17
PC (36:1)ME6568550.160.180.050.050.033.694.20
PC (38:4) AME6568680.160.170.050.050.043.614.08
DG (34:1)ME6568081.071.28NANANA0.790.76
DG (36:2)ME6568101.111.33NANANA0.680.74
plasmenyl-PE (34:2)ME6569290.670.81NANANA1.261.44
Ceramide (d18:1/23:0)ME6568000.880.96NANANA1.031.19
CholesterolME6568041.101.210.040.04NA1.191.27
DG (36:3)ME6568111.521.84NANANA0.050.11
TG (14:0/14:0/14:0)ME6569681.891.950.020.02NANANA
TG (49:3)ME6569851.821.900.010.01NANANA
TG (50:5)ME6569911.841.880.010.01NANANA
TG (46:3)ME6569761.841.890.010.01NANANA
TG (52:6)ME6570031.841.890.010.01NANANA
TG (44:2)ME6569721.841.870.020.02NANANA
TG (51:4)ME6569961.851.870.010.01NANANA
TG (58:4) AME6570331.901.50NANANA0.010.04
TG (62:3)ME6570431.881.43NANANA0.070.09
TG (53:1)ME6570041.991.710.010.01NANANA
TG (49:0)ME6569821.771.68NANANA0.010.01
TG (56:5)ME6570251.801.65NANANA0.000.01
TG (58:5)ME6570341.811.62NANANA0.010.02
TG (58:8)ME6570371.801.63NANANA0.010.03
TG (52:0)ME6569973.322.870.010.010.000.010.02
TG (54:2)ME6570103.392.790.020.010.000.000.01
TG (52:1)ME6569982.902.790.010.010.000.000.01
TG (50:3)ME6569892.922.920.010.010.000.000.01
TG (46:1)ME6569743.002.960.010.010.000.010.01
TG (48:2)ME6569793.053.030.020.020.000.000.01
TG (48:0)ME6569773.023.190.020.020.000.020.03
TG (54:3)ME6570113.252.940.020.020.000.000.02
TG (54:5)ME6570133.262.950.020.010.000.000.01
TG (50:0)ME6569863.242.970.020.010.000.010.02
TG (54:4)ME6570123.232.980.020.020.000.000.01
TG (50:1)ME6569873.173.020.030.020.000.010.03
TG (52:2)ME6569993.163.030.030.020.000.010.02
TG (48:1)ME6569783.163.050.020.010.000.010.02
TG (52:4)ME6570013.173.050.020.010.000.000.01
TG (52:3)ME6570003.143.070.030.020.000.000.01
TG (46:0)ME6569733.123.100.020.010.000.010.01
TG (50:2)ME6569883.113.100.020.020.000.010.01
TG (58:6)ME6570352.572.470.010.01NA0.000.01
TG (56:3)ME6570232.852.400.010.01NA0.010.02
TG (58:7)ME6570362.702.440.020.01NA0.010.02
TG (56:4)ME6570242.802.490.010.00NA0.010.02
TG (51:1)ME6569932.762.530.010.01NA0.000.01
TG (54:6)ME6570142.782.510.010.01NA0.000.01
TG (44:1)ME6569712.552.630.010.01NA0.000.00
TG (51:2)ME6569942.672.620.010.01NA0.000.01
TG (48:3)ME6569802.652.670.010.01NA0.000.01
TG (51:3)ME6569952.652.660.010.01NA0.000.01
TG (49:2)ME6569842.652.650.010.01NA0.010.01
TG (46:2)ME6569752.662.650.010.01NA0.000.01
TG (50:4)ME6569902.662.650.010.01NA0.000.01
TG (56:7)ME6570272.692.590.020.01NA0.010.01
TG (56:6)ME6570262.712.590.010.01NA0.010.02
TG (52:5)ME6570022.712.600.010.01NA0.000.01
TG (53:4)ME6570072.712.590.010.01NA0.000.01
TG (53:3)ME6570062.702.540.030.02NA0.010.03
TG (49:1)ME6569832.732.560.010.01NA0.010.02
TG (53:2)ME6570052.732.550.020.01NA0.000.01
TG (60:3)ME6570402.951.950.020.02NA0.040.06
TG (54:1)ME6570093.052.200.010.01NA0.000.01
TG (56:2)ME6570223.052.190.010.01NA0.010.02
TG (56:1)ME6570213.072.160.010.01NA0.010.02
TG (58:1)ME6570293.062.140.020.01NA0.030.03
TG (58:2)ME6570313.042.040.010.01NA0.020.03
TG (58:3)ME6570322.992.080.010.01NA0.020.04
TG (60:2)ME6570393.002.070.020.01NA0.020.03

Factors:

F1Treatment:Human Adipocytes grown in the ABSENCE of SKOV3ip1 OvCa Cells (Control) | Time Point:4 hours
F2Treatment:Human Adipocytes grown in the PRESENCE of SKOV3ip1 OvCa cells (Co-Culture) | Time Point:4 hours
F3Treatment:Media from Human Adipocytes and SKOV3ip1 OvCa Cells Co-Cultured | Time Point:4 hours
F4Treatment:Media from Human Adipocytes Culturing Only | Time Point:4 hours
F5Treatment:Media from SKOV3ip1 OvCa Cells Culturing Only | Time Point:4 hours
F6Treatment:SKOV3ip1 OvCa cells grown in the ABSENCE of human adipocytes (Control) | Time Point:4 hours
F7Treatment:SKOV3ip1 OvCa cells grown in the PRESENCE of Human Adipocytes (Co-Culture) | Time Point:4 hours
Data matrix
  logo